On-Demand Webinar Event: Unlock GPCR Fragment Screening for Drug Discovery

GPCRs are notoriously difficult to study due to their intrinsic protein instability. By utilizing the sensitivity of Grating Coupled Interferometry (GCI) technology combined with non-clog microfluidics, these pesky membrane proteins can be analyzed successfully.

Evotec, a life science company who is committed to advancing drug discovery and development through their collaborations with biotech, pharma, foundations, academia and government agencies, has successfully harnessed Grating Coupled Interferometry (GCI) for the fragment screening of GPCRs.

Speakers

• Edoardo Fabini - Principal Scientist, Evotec

• Edward Fitzgerald - Segment Lead - Drug Discovery, Malvern Panalytical

What will you learn from this webinar event? 

• What are GPCRs and why study them

• Challenges in studying GPCRs

• Evotec’s solution to studying GPCRs using GCI technology

• A summary of Evotec’s workflow and data covering:

  • Assay development

  • Fragment screening

  • Binding confirmation

Join this on-demand webinar event to learn more!